Advertisement

Effect of Nonautonomic Drugs on the Vesical Neck

  • Om P. Khanna

Abstract

As a result of expanding knowledge and better understanding of neurophysiology and neuropharmacology, effective pharmacotherapy is now being used for the treatment of various disorders of micturition. In the past, drug use was aimed mainly at increasing or decreasing the activity of bladder smooth muscle. Now drugs are being used to influence not only the activity of bladder muscle but the function of the vesical neck, urethra, striated sphincter, and prostate.

Keywords

Detrusor Muscle Urethral Pressure Contractile Effect Proximal Urethra Oxybutynin Chloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abdel-Rahman M, Coulombe A, Elhilali MM: Detrusor dynamics. II. Effect of prostaglandins and their synthesis inhibitor on stress-relaxation time course. Invest Urol 18:281–284, 1981PubMedGoogle Scholar
  2. 2.
    Abrams PH, Dunn M: A double blind trial of bromocryptine in the treatment of idiopathic bladder instability. Br J Urol 51:24–27, 1979PubMedCrossRefGoogle Scholar
  3. 3.
    Abrams PH, Feneley RCL: The actions of prostaglandins on the smooth muscle of the human urinary tract in vitro. Br J Urol 47:909–915, 1976CrossRefGoogle Scholar
  4. 4.
    Abrams PH, Sykes JAC, Rose AJ, Rogers AF: The synthesis and release of prostaglandins by human urinary bladder muscle in vitro. Invest Urol 16:346–348, 1979PubMedGoogle Scholar
  5. 5.
    Albert DJ, Jacobs S, Persky L: Bradykinin and urinary tract smooth muscle. Curr Top Surg Res 2:327–333, 1970Google Scholar
  6. 6.
    Albert DJ, Jacobs S, Persky L: In vitro effect of bradykinin on mucosal covered bladder muscle. Surg Forum 21:538–540, 1970PubMedGoogle Scholar
  7. 7.
    Aim P: Cholinergic innervation of the human urethra and urinary bladder. Acta Pharmacol Toxicol (Copenh) 43:56–62, 1978Google Scholar
  8. 8.
    Aim P, Alumets J, Brodin E, Hakanson H, Nilsson G, Sjöberg N-O, Sundler F: Peptidergic (substance P) nerves in the genitourinary tract. Neuroscience 3: 419–425, 1978CrossRefGoogle Scholar
  9. 9.
    Aim P, Alumets J, Ek A, Sundler F: Peptidergic (VIP) nerves in the human urinary tract. In: Proceedings, IX Annual Meeting, International Continence Society. Guidotti, Rome, 1979, p 147Google Scholar
  10. 10.
    Aim P, Alumets J, Hakanson R, Sundler F: Peptidergic (vasoactive intestinal peptide) nerves in the genitourinary tract. Neuroscience 2:751–754, 1977CrossRefGoogle Scholar
  11. 11.
    Ambache N, Zar MA: Noncholinergic transmission by post-ganglionic motor neurones in the mammalian bladder. J Physiol (Lond) 210:761–783, 1970Google Scholar
  12. 12.
    Andersson K-E, Ek A, Persson CGA: Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol Scand 100:165–171, 1977PubMedCrossRefGoogle Scholar
  13. 13.
    Andersson K-E, Forman A: Effects of prostaglan-dins on the smooth muscle of the urinary tract. Acta Pharmacol Toxicol (Copenh) 43:90–95, 1978CrossRefGoogle Scholar
  14. 14.
    Andersson K-E, Henriksson L, Ulmsten U: Effects of prostaglandin E2 applied locally on intravesical and intraurethral pressures in women. Eur Urol 4:366–369, 1978PubMedGoogle Scholar
  15. 15.
    Andersson K-E, Husted S, Sjogren C: Contribution of prostaglandins to the adenosine triphos- phate-induced contraction of rabbit urinary bladder. Br J Pharmacol 70:443–452, 1980PubMedGoogle Scholar
  16. 16.
    Andersson K-E, Persson CGA, Aim P, Kullander S, Ulmsten U: Effects of acetylcholine, nor-adrenaline, and prostaglandins on the isolated, perfused human fetal urethra. Acta Physiol Scand 104:394–401, 1978PubMedCrossRefGoogle Scholar
  17. 17.
    Angelucci L, Falconieri G, Negri L: Bioassay of vasopressin on the rabbit isolated urinary bladder. J Pharm Pharmacol 26:193–196, 1974PubMedCrossRefGoogle Scholar
  18. 18.
    Appell RA, England HR, Hussell AR, McGuire EJ: The effects of epidural anesthesia on the urethral closure pressure profile in patients with prostatic enlargement. J Urol 124:410–411, 1980PubMedGoogle Scholar
  19. 19.
    Ash ASF, Schild HO: Receptors mediating some actions of histamine. Br J Pharmacol Chemother 27:427–439, 1966PubMedGoogle Scholar
  20. 20.
    Awad SA, Bryniak S, Downie JW, Bruce AW: The treatment of the uninhibited bladder with dicyclomine. J Urol 117:161–163, 1977PubMedGoogle Scholar
  21. 21.
    Benson GS, Raezer DM, Corriere JN Jr: Effect of muscle length on adrenergic stimulation of canine detrusor. Surg Forum 25:552–553, 1974PubMedGoogle Scholar
  22. 22.
    Benson GS, Sarshik SA, Raezer DM, Wein AJ: Bladder muscle contractility: comparative effects and mechanisms of action of atropine, propantheline, flavoxate and imipramine. Urology 9:31–35, 1977PubMedCrossRefGoogle Scholar
  23. 23.
    Bissada NK, Finkbeiner AE: In vitro action of digitalis on guinea pig detrusor and urethra. Invest Urol 17:1–2, 1979PubMedGoogle Scholar
  24. 24.
    Black JW, Duncan WA, Durant CJ, Ganellin CR, Parsons EM: Definition and antagonism of histamine H2 receptors. Nature 236:385–390, 1972PubMedCrossRefGoogle Scholar
  25. 25.
    Bodeker J, Salim SH, Nagel R: Wirkingen von Nifedipin bei urologischen Patienten. Dtsch Med Wochenschr 101:1866–1868, 1976PubMedCrossRefGoogle Scholar
  26. 26.
    Bradley DV, Cazort RJ: Relief of bladder spasm by flavoxate: a comparative study. J Clin Pharmacol 10:65–68, 1970Google Scholar
  27. 27.
    Brown C, Burnstock G, Cocks T: Effects of adenosine 5’-triphosphate (ATP) and β-γ-methylene ATP on the rat urinary bladder. Br J Pharmacol 65:97–102, 1979PubMedGoogle Scholar
  28. 28.
    Bultitude MI, Hills NH, Shuttleworth KED: Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br J Urol 48:631–637, 1976PubMedCrossRefGoogle Scholar
  29. 29.
    Burnstock G, Dumsday B, Smythe A: Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerve releasing a purine nucleotide. Br J Pharmacol 44:451–461, 1972PubMedGoogle Scholar
  30. 30.
    Caine M, Raz S: Some clinical implications of adrenergic receptors in the urinary tract. Arch Surg 110:247–250, 1975PubMedGoogle Scholar
  31. 31.
    Caine M, Raz S, Zeigler M: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 47:193–202, 1975PubMedCrossRefGoogle Scholar
  32. 32.
    Cardozo LD, Stanton SL: A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol 123:399–401, 1980PubMedGoogle Scholar
  33. 32a.
    Chadduck WM, Loar CR, Denton IC: Vesical hypotonicity with diazepam. J Urol 109: 1005–1006, 1973PubMedGoogle Scholar
  34. 33.
    Clark AL, Mitchelson F: The effect of 4-(l- naphthyl-vinyl)pyridine (NVP), a choline acety- lase inhibitor, on autonomically innervated tissues of the rat. Eur J Pharmacol 27:34–39, 1974PubMedCrossRefGoogle Scholar
  35. 34.
    Creed KE, Tulloch AGS: The effect of pelvic nerve stimulation and some drugs on the urethra and bladder of the dog. Br J Urol 50:398–405, 1978PubMedCrossRefGoogle Scholar
  36. 35.
    Dangor J, Johns A: The effect of theophylline on the responses of the guinea-pig urinary bladder to nerve stimulation, adenosine 5’-triphosphate and histamine. Arch Int Pharmacodyn 236:125–130, 1978PubMedGoogle Scholar
  37. 36.
    Dean DM, Downie JW: Contribution of adrenergic and purinergic neurotransmission to contraction in rabbit detrusor. J Pharmacol Exp Ther 207:431–445, 1978PubMedGoogle Scholar
  38. 37.
    Dean DM, Downie JW: Interaction of prostaglandins and adenosine 5’-triphosphate in the noncholinergic neurotransmission in rabbit detrusor. Prostaglandins 16:245–251, 1978PubMedCrossRefGoogle Scholar
  39. 38.
    Delaere KPJ, Debruyne FMJ, Moonen WA: Has bromocriptine a place in the treatment of the unstable bladder? Br J Urol 50:169–171, 1978PubMedCrossRefGoogle Scholar
  40. 39.
    Desmond AD, Bultitude MI, Hills NH, Shuttleworth KED: Clinical experience with intravesical prostaglandin E2: a prospective study of 36 patients. Br J Urol 52:357–366, 1980PubMedCrossRefGoogle Scholar
  41. 40.
    Dhattiwala AS, Jindal MN, Kelkar VV: Effects of some drugs on the responses of the rat isolated, innervated urinary bladder to indirect electrical stimulation. Br J Pharmacol 39:738–747, 1970PubMedGoogle Scholar
  42. 41.
    Diokno AC, Koppenhoefer R: Bethanechol chloride in neurogenic bladder dysfunction. Urology 8:455–458, 1976PubMedCrossRefGoogle Scholar
  43. 42.
    Diokno AC, Lapides J: Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol 108:307–309, 1972PubMedGoogle Scholar
  44. 43.
    Ditman KS, Gottlieb L: Transient enuresis from chlordiazepoxide and diazepam. Am J Psychiatry 120: 910–911, 1964PubMedGoogle Scholar
  45. 44.
    Donker PJ, Dröes JThPM, Van Ulden BM: Anat-omy of the musculature and innervation of the bladder and the urethra. In Williams DI, Chisholm GD (eds.): Scientific Foundation of Urology, Vol 7. Yearbook, Chicago, 1976, pp 32 - 39Google Scholar
  46. 45.
    Downie JW, Dean DM: The contribution of cholinergic postganglionic neurotransmission to contractions of rabbit detrusor. J Pharmacol Exp Ther 203:417–425, 1977PubMedGoogle Scholar
  47. 46.
    Downie JW, Dean DM, Carro-Ciampi G, Awad SA: A difference in sensitivity to alpha-adrenergic agonists exhibited by detrusor and bladder neck of rabbit. Can J Physiol Pharmacol 53:525–530, 1975PubMedCrossRefGoogle Scholar
  48. 47.
    Downie JW, McGuire RP: Antagonism of calcium-induced contraction in potassium-depolarized rabbit detrusor muscle strips by dicyclomine hydrochloride and rociverine. Can J Physiol Pharmacol 59:853–856, 1981PubMedCrossRefGoogle Scholar
  49. 48.
    Downie JW, Rouffignac S: Response of rabbit detrusor muscle to bradykinin. Life Sci 28:603–608, 1981PubMedCrossRefGoogle Scholar
  50. 49.
    Downie JW, Twiddy DAS, Awad SA: Antimus-carinic and noncompetitive antagonist properties of dicyclomine hydrochloride in isolated human and rabbit bladder muscle. J Pharmacol Exp Ther 201:662–668, 1977PubMedGoogle Scholar
  51. 50.
    Doyle PT, Briscoe CE: The effects of drugs and anaesthetic agents on the urinary bladder and sphincters. Br J Urol 48:329–335, 1976PubMedCrossRefGoogle Scholar
  52. 51.
    Droes JThPM: Observations on the musculature of the urinary bladder and the urethra in the human foetus. Br J Urol 46:179–185, 1974CrossRefGoogle Scholar
  53. 52.
    Dumsday B: Atropine-resistance of the urinary bladder innervation. J Pharm Pharmacol 23:222–225, 1971PubMedCrossRefGoogle Scholar
  54. 53.
    Eakins KE, Rajadhyaksha V, Schroer R: Prostaglandin antagonism by sodium p-benzyl-4-[1-oxo- 2(4-chlorobenzyl)-3-phenylpropyl] phenylphosphonate (N-0164). Br J Pharmacol 58:333–339, 1976PubMedGoogle Scholar
  55. 54.
    Edmunds CW, Roth GB: The point of attack of certain drugs acting on the periphery. I. Action on the bladder. J Pharmacol Exp Ther 15:189–199, 1920Google Scholar
  56. 55.
    Ek A, Aim P, Andersson K-E, Persson CGA: Adrenoceptor and cholinoceptor mediated responses of the isolated human urethra. Scand J Urol Nephrol 11:97–102, 1977PubMedCrossRefGoogle Scholar
  57. 56.
    Ekman G, Andersson K-E, Rud T, Ulmsten U: A double-blind, cross-over study of the effects of terodiline in women with unstable bladder. Acta Pharmacol Toxicol [Suppl I] (Copenh) 46:39–43, 1980CrossRefGoogle Scholar
  58. 57.
    Elmer M: Inhibitory -adrenoceptors in the urinary bladder of the rat. Life Sci 15:273–280, 1974PubMedCrossRefGoogle Scholar
  59. 58.
    Erspamer V, Ronzoni G, Falconieri Erspamer G: Effects of active peptides on the isolated muscle of the human urinary bladder. Invest Urol 18:302–304, 1981PubMedGoogle Scholar
  60. 59.
    Falconieri Erspamer G, Negri L, Piccinelli D: The use of preparations of urinary bladder smooth muscle for bioassay of and discrimination between polypeptides. Naunyn Schmiedebergs Arch Pharmacol 279:61–74, 1973CrossRefGoogle Scholar
  61. 60.
    Farrar DJ, Osborne JL: The use of bromocriptine in the treatment of the unstable bladder. Br J Urol 48:235–238, 1976PubMedGoogle Scholar
  62. 61.
    Farrar DJ, Pryor JS: The effect of bromocriptine in patients with benign prostatic hypertrophy. Br J Urol 48:73–75, 1976PubMedCrossRefGoogle Scholar
  63. 62.
    Finkbeiner AE, Bissada NK: In vitro study of phenothiazine effects on urinary bladder. Urology 14:206–208, 1979PubMedCrossRefGoogle Scholar
  64. 63.
    Fischer CP, Diokno A, Lapides J: The anticholinergic effect of dicyclomine hydrochloride in un-inhibited neurogenic bladder dysfunction. J Urol 120:328–329, 1978PubMedGoogle Scholar
  65. 64.
    Flores AGA, Sharp GWG: Endogenous prostaglandins and osmotic water flow in the toad bladder. Am J Physiol 233:1392–1397, 1972Google Scholar
  66. 65.
    Forman A, Andersson K-E, Henriksson L, Rud T, Ulmsten U: Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo. Acta Pharmacol Toxicol (Copenh) 43:111–118, 1978CrossRefGoogle Scholar
  67. 66.
    Fredericks CM: Characterization of the rabbit detrusor response to histamine through pharma-cologic antagonism. Pharmacology 13:5–11, 1975PubMedCrossRefGoogle Scholar
  68. 67.
    Fredericks CM, Anderson GF, Kreulen DL: A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor. Invest Urol 12:317–319, 1975PubMedGoogle Scholar
  69. 68.
    Fredericks CM, Green RL, Anderson GF: Comparative in vitro effects of imipramine, oxybutynin, and flavoxate on rabbit detrusor. Urology 12:487–491, 1978PubMedCrossRefGoogle Scholar
  70. 69.
    Ghoneim MA, Fretin J A, Gagnon DJ, Lebel E, Van Lier J, Arsenault A, Susset JG: The influence of vesical distension on the urethral resistance to flow: a possible role for prostaglandins? J Urol 116:739–743, 1976PubMedGoogle Scholar
  71. 70.
    Gilmore NJ, Vane JR: Hormones released into the circulation when the urinary bladder of the anaesthetized dog is distended. Clin Sci 41:69–83, 1971PubMedGoogle Scholar
  72. 71.
    Gosling J: The structure of the bladder and urethra in relation to function. Urol Clin North Am 6:31–38, 1979PubMedGoogle Scholar
  73. 72.
    Gregory JG, Wein AJ, Schoenberg HW: A comparison of the action of Tofranil and Pro-Banthine on the urinary bladder. Invest Urol 12:233–235, 1974PubMedGoogle Scholar
  74. 73.
    Griinberger W, Tulzer H: Therapy of postoperative urinary retention with prostaglandins. Geburtshilfe Frauenheilkd 41:20–22, 1981CrossRefGoogle Scholar
  75. 74.
    Gyermek L: Action of 5-hydroxytryptamine on the urinary bladder of the dog. Arch Int Pharmacodyn 137:137–144, 1962PubMedGoogle Scholar
  76. 75.
    Hill DW: Quoted by Doyle PT, Briscoe CE: The effects of drugs and anaesthetic agents on the urinary bladder and sphincters. Br J Urol 48:329–335, 1976CrossRefGoogle Scholar
  77. 76.
    Hills NH: Prostaglandins and tone in isolated strips of mammalian bladder. Br J Pharmacol 54:464P–465P, 1976Google Scholar
  78. 77.
    Hodgson BJ, Dumas S, Boiling DR, Heesch CM: Effects of estrogen on sensitivity of rabbit bladder and urethra to phenylephrine. Invest Urol 16:67–69, 1978PubMedGoogle Scholar
  79. 78.
    Hokfelt T, Schultzberg M, Elde R, Nilsson G, Terenius L, Said S, Goldstein M: Peptide neurons in peripheral tissues including the urinary tract: immunohistochemical studies. Acta Pharmacol Toxicol (Copenh) 43:79–89, 1978CrossRefGoogle Scholar
  80. 79.
    Hukovic S, Rand MJ, Vanov S: Observation of an isolated, innervated preparation of rat urinary bladder. Br J Pharmacol 24:178–188, 1965Google Scholar
  81. 80.
    Husted S, Andersson K-E, Ostergaard JR: Anti-cholinergic and calcium antagonistic effects of ter- odiline in rabbit urinary bladder. Acta Pharmacol Toxicol [Suppl I] (Copenh) 46:20–30, 1980CrossRefGoogle Scholar
  82. 81.
    Husted S, Sjogren C, Andersson K-E: Mechanisms of the responses to non-cholinergic, non- adrenergic nerve stimulation and to ATP in isolated rabbit urinary bladder: evidence for ADP- evoked prostaglandin release. Acta Pharmacol Toxicol (Copenh) 47:84–92, 1980CrossRefGoogle Scholar
  83. 82.
    Hutch JA: The internal urinary sphincter: a double loop system. J Urol 105:375–383, 1971PubMedGoogle Scholar
  84. 83.
    Innes IR, Nickerson M: Norepinephrine, epinephrine and the sympathomimetic amines. In Goodman LS, Gilman A (eds.): The Pharmacological Basis of Therapeutics, 5th ed. Macmillan, New York, 1975, pp 477–513Google Scholar
  85. 84.
    Johns A: The effect of vasoactive intestinal poly-peptide on the urinary bladder and taenia coli of the guinea pig. Can J Physiol Pharmacol 57:106–108, 1979PubMedCrossRefGoogle Scholar
  86. 85.
    Johns A, Paton DM: Effects of indomethacin on atropine resistant transmission in rabbit and monkey urinary bladder: evidence of involvement of prostaglandins in transmission. Prostaglandins 13:245–254, 1977PubMedCrossRefGoogle Scholar
  87. 86.
    Johns A, Paton DM: Evidence for a role of prostaglandins on atropine resistant transmission in the mammalian urinary bladder. Prostaglandins 11:595–597, 1976PubMedCrossRefGoogle Scholar
  88. 87.
    Johns A, Tasker JJ, Johnson CE, Theman MA, Paton DM: The mechanism of action of dicyclomine hydrochloride on rabbit detrusor muscle and vas deferens. Arch Int Pharmacodyn Ther 224:109–113, 1976PubMedGoogle Scholar
  89. 88.
    Khalaf IM, Ghoneim MA, Elhilali MM: The effect of exogenous prostaglandins F2a and E2 and indomethacin on micturition. Br J Urol 53:21–28, 1981PubMedCrossRefGoogle Scholar
  90. 89.
    Khalaf IM, Lehoux JG, Elshawarby LA, Elhilali MM: Release of prostaglandins into the pelvic venous blood of dogs in response to vesical disten-sion and pelvic nerve stimulation. Invest Urol 17:244–247, 1979PubMedGoogle Scholar
  91. 90.
    Khalaf IM, Rioux F, Quirion R, Elhilali MM: Intravesical prostaglandin: release and effect of bladder instillation on some micturition parameters. Br J Urol 52: 351–356,1980PubMedCrossRefGoogle Scholar
  92. 91.
    Khanna OP, Barbieri EJ, Altamura M, McMichael RF: Vesicourethral smooth muscle: function and relation to structure. Urology 18:211–218, 1981PubMedCrossRefGoogle Scholar
  93. 92.
    Khanna OP, Barbieri EJ, McMichael RF: Effects of prostaglandins on vesicourethral smooth muscle of rabbit. Urology 12:674–681, 1978PubMedCrossRefGoogle Scholar
  94. 92.
    Khanna OP, Barbieri EJ, McMichael RF: Effects of prostaglandins on vesicourethral smooth muscle of rabbit. Urology 12:674–681, 1978PubMedCrossRefGoogle Scholar
  95. 94.
    Khanna OP, DiGregorio GJ, Barbieri EJ, McMichael RF, Ruch E: In vitro study of antispasmodic effects of dicyclomine hydrochloride on vesicourethral smooth muscle of guinea pig and rabbit. Urology 13:457–462, 1979PubMedCrossRefGoogle Scholar
  96. 95.
    Khanna OP, DiGregorio GJ, Sample RG, McMichael RF: Histamine receptors in urethrovesical smooth muscle. Urology 10:375–381, 1977PubMedCrossRefGoogle Scholar
  97. 96.
    Khanna OP, Elkouss G, Heber D, Gonick P. Imipramine hydrochloride: pharmacodynamic ef-fects on lower urinary tract of female dogs. Urology 6:48–51, 1975CrossRefGoogle Scholar
  98. 97.
    Kindall L, Nickels TT: Allergy of the pelvic urinary tract in the female. J Urol 61:222–232, 1949PubMedGoogle Scholar
  99. 98.
    Koff SA, Solomon MH, Lane GA, Lieding KG:Urodynamic studies in anesthetized children. J Urol 123:61–63, 1980PubMedGoogle Scholar
  100. 99.
    Kohler FP, Morales PA: Cystometric evaluation of flavoxate hydrochloride in normal and neurogenic bladders. J Urol 100:729–730, 1968PubMedGoogle Scholar
  101. 100.
    Kondo A, Kobayashi M, Otani T, Takita T, Narita H: Supersensitivity to prostaglandin in chronic neurogenic bladders. Br J Urol 52:290–294, 1980PubMedCrossRefGoogle Scholar
  102. 101.
    Krainin P, Ney C: Disturbances of urination after administration of certain newer drugs. N Engl J Med 253:1111–1114, 1955PubMedCrossRefGoogle Scholar
  103. 102.
    Krell RD, McCoy JL, Ridley PT: Pharmacological characterization of the excitatory innervation to the guinea pig urinary bladder in vitro: evidence for both cholinergic and non-adrenergic- noncholinergic neurotransmission. Br J Pharmacol 74:15–22, 1981PubMedGoogle Scholar
  104. 103.
    Labay P, Boyarsky S: The action of imipramine on the bladder musculature. J Urol 109:385–387, 1973PubMedGoogle Scholar
  105. 104.
    Langworthy OR, Kolb LC, Lewis LG: Experimental and clinical studies with suggestions as to diagnosis and treatment. In Langworthy OR, Kolb LC, Lewis LG (eds.): Physiology of Micturition. Williams & Wilkins, Baltimore, 1940, p 232Google Scholar
  106. 105.
    Lapides J: Structure and function of the internal vesical sphincter. J Urol 80:341–353, 1958PubMedGoogle Scholar
  107. 106.
    Lapides J, Friend CR, Ajemian EP, Sonda LP: Comparison of action of oral and parenteral bethanechol chloride upon the urinary bladder. Invest Urol 1:94–97, 1963PubMedGoogle Scholar
  108. 107.
    Larsson C: Effects of prostaglandins on the field- stimulated rat isolated urinary bladder. Prostaglandins 15:701, 1978 (abstract)CrossRefGoogle Scholar
  109. 108.
    Larsson LI, Fahrenkrug J, SchafFalitzky de Muckadell OB: Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. Science 197:1374–1375, 1977PubMedCrossRefGoogle Scholar
  110. 109.
    Laval K-U, Hannapel J, Lutzeyer W: Effects of beta-adrenergic stimulating and blocking agents on the dynamics of the human bladder outlet. Urol Int 33:366–369, 1978PubMedCrossRefGoogle Scholar
  111. 110.
    Leoni J, Wein A J, Schoenberg HW: The effects of isoproterenol and aminophylline on detrusor muscle contractility in an organ bath apparatus. Invest Urol 10:458–463, 1973PubMedGoogle Scholar
  112. 111.
    Levin RM, Shofer PS, Wein AJ: Cholinergic, adrenergic and purinergic response of sequential strips of rabbit urinary bladder. J Pharmacol Exp Ther 212:536–540, 1980PubMedGoogle Scholar
  113. 112.
    Levin RM, Shofer FS, Wein AJ: Estrogen-induced alterations in the autonomic responses of the rabbit urinary bladder. J Pharmacol Exp Ther 215:614–618, 1980PubMedGoogle Scholar
  114. 113.
    Lipshultz LI, Rohner TJ, Curry TH, Raezer DM, Schoenberg HW: The effect of imipramine on in vitro dog bladder muscle contractility. Invest Urol 11:182–185, 1973PubMedGoogle Scholar
  115. 114.
    Mánsson W, Sundin T, Gullberg B: Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. Scand J Urol Nephrol 14:139–141, 1980PubMedCrossRefGoogle Scholar
  116. 115.
    Matsumura S, Taira N, Hashimoto K: The pharmacological behavior of the urinary bladder and its vasculature of the dog. Tohoku J Exp Med 96:247–258, 1968PubMedCrossRefGoogle Scholar
  117. 116.
    McNeal JE: The prostate and prostatic urethra: a morphologic synthesis. J Urol 107:1008–1016, 1972PubMedGoogle Scholar
  118. 117.
    Merrill DC, Markland C: A laboratory investigation of the effect of phenothiazines on urinary bladder function. Invest Urol 7:532–542, 1970PubMedGoogle Scholar
  119. 118.
    Merrill DC, Markland C: Vesical dysfunction induced by the major tranquilizers. J Urol 107:769–771, 1972PubMedGoogle Scholar
  120. 119.
    Moisey CU, Stephenson TP, Brendler CB: The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Br J Urol 52:472–475, 1980PubMedCrossRefGoogle Scholar
  121. 120.
    Muellner SR, Hamilton JB: The effect of testosterone propionate on the tonus of the urinary bladder. J Urol 52:139–147, 1944Google Scholar
  122. 121.
    Needleman P, Minkes MS, Douglas JR Jr: Stimulation of prostaglandin biosynthesis by adenine nucleotides: profile of prostaglandin release by perfused organs. Circ Res 34:455–460, 1974PubMedGoogle Scholar
  123. 122.
    Nergárdh A, Boréus LO: Autonomic receptor function in the lower urinary tract of man and cat. Scand J Urol Nephrol 6:32–36, 1972CrossRefGoogle Scholar
  124. 123.
    Nergárdh A, Boréus LO: The functional role of cholinergic receptors in the outlet region of the urinary bladder: an in vitro study in the cat. Acta Pharmacol Toxicol (Copenh) 32:467–480, 1973CrossRefGoogle Scholar
  125. 124.
    Norlén L, Sundin T, Waagstein F: Beta-adrenoceptor stimulation of the human urinary bladder in vivo. Acta Pharmacol Toxicol (Copenh) 43:26–30, 1978CrossRefGoogle Scholar
  126. 125.
    O’Boyle PJ, Parsons KF: Primary vesical sensory urgency: a clinical trial of bromocriptine. Br J Urol 51:200–203, 1979PubMedCrossRefGoogle Scholar
  127. 126.
    Olubadewo JO: The effect of imipramine on rat detrusor muscle contractility. Arch Int Pharmacodyn 245:84–94, 1980PubMedGoogle Scholar
  128. 127.
    Palermo LM, Zimskind PD: Effect of caffeine on urethral pressure. Urology 10:320–324, 1977PubMedCrossRefGoogle Scholar
  129. 128.
    Paulson DF: Oxybutynin chloride in control of post-transurethral vesical pain and spasm. Urology 11:237–238, 1978PubMedCrossRefGoogle Scholar
  130. 129.
    Pedersen E, Bjarzason EV, Hansen P-H: The effect of flavoxate on neurogenic bladder dysfunction. Acta Neurol Scand [Suppl] 51:487–488, 1972Google Scholar
  131. 130.
    Persson CGA: Inhibitory effect at the bladder-urethral junction. Acta Physiol Scand 97:139–141, 1976PubMedCrossRefGoogle Scholar
  132. 131.
    Persson CG A, Andersson K-E: Adrenoceptor and cholinoceptor mediated effects in the isolated urethra of cat and guinea pig. Clin Exp Pharmacol Physiol 3:415–426, 1976PubMedCrossRefGoogle Scholar
  133. 132.
    Poggesi L, Nicita G, Castellani S, Selli C, Galanti G, Turini D, Masotti G: The role of prostaglandins in the maintenance of the tone of the rabbit urinary bladder. Invest Urol 17:454–458, 1980PubMedGoogle Scholar
  134. 133.
    Raz S: Adrenergic influence on the internal urinary sphincter. Isr J Med Sci 10:608–611, 1974PubMedGoogle Scholar
  135. 134.
    Raz S, Caine M: Adrenergic receptors in the female canine urethra. Invest Urol 9:319–323, 1972PubMedGoogle Scholar
  136. 135.
    Raz S, Zeigler M, Caine M: The effect of di-phenylhydantoin on the urethra. Invest Urol 10:293–294, 1973PubMedGoogle Scholar
  137. 136.
    Raz S, Zeigler M, Caine M: The effect of progesterone on the adrenergic receptors of the urethra. Br J Urol 45:131–135, 1973PubMedCrossRefGoogle Scholar
  138. 137.
    Rohner TJ Jr, Hannigan J: Effect of norepinephrine and isoproterenol on in vitro detrusor muscle contractility and cyclic AMP content. Invest Urol 17:324–327, 1980PubMedGoogle Scholar
  139. 138.
    Rohner TJ Jr, Raezer DM, Wein AJ, Schoenberg HW: Contractile responses of dog bladder neck muscle to adrenergic drugs. J Urol 105:657–661, 1971PubMedGoogle Scholar
  140. 139.
    Rud T, Andersson K-E, Boye N, Ulmsten U: Terodiline inhibition of human bladder contraction: effects in vitro and in women with unstable bladder. Acta Pharmacol Toxicol [Suppl I] (Co- penh) 46:31–38, 1980CrossRefGoogle Scholar
  141. 140.
    Rud T, Andersson K-E, Ulmsten U: Effects of nifedipine in women with unstable bladders. Urol Int 34:421–429, 1979PubMedCrossRefGoogle Scholar
  142. 141.
    Sadoughi N, Razvi M, Abiin RJ, Bush IM: The effects of digitalis on the bladder in man. J Urol 113:178–179, 1975PubMedGoogle Scholar
  143. 142.
    Sadoughi N, Tandoc V, Abiin RJ, Bush IM: Effects of digitalis on urinary bladder. Urology 11:582–583, 1973CrossRefGoogle Scholar
  144. 143.
    Salmon UJ, Walter RI, Geist SH: The use of estrogens in the treatment of dysuria and incontinence in post-menopausal women. Am J Obstet Gynecol 42:845–851, 1941Google Scholar
  145. 144.
    Sanner JH: Substances that inhibit the action of prostaglandins. Arch Intern Med 133:133–146, 1974PubMedCrossRefGoogle Scholar
  146. 145.
    Saum WR, de Groat WC: The actions of 5-hy- droxytryptamine on the urinary bladder and on vesical autonomic ganglia in the cat. J Pharmacol Exp Ther 185:70–83, 1973PubMedGoogle Scholar
  147. 146.
    Schreiter F, Fuchs P, Stockamp K: Estrogenic sensitivity of alpha-receptors in the urethral musculature. Urol Int 31:13–18, 1976PubMedCrossRefGoogle Scholar
  148. 147.
    Singh I, Singh A: Neurones histaminergiques, kininergiques et hydroxytryptaminergiques dans les ganglions intramuraux du muscle gastrique et du muscle vesical de la grenouille. J Physiol (Lond) 62:431–439, 1970Google Scholar
  149. 148.
    Sjogren C, Andersson K-E: Effects of cholirecep- tor blocking drugs, adrenoceptor stimulants and calcium antagonists on the transmurally stimulated guinea pig urinary bladder in vitro and in vivo. Acta Pharmacol Toxicol (Copenh) 44:228–234, 1979CrossRefGoogle Scholar
  150. 149.
    Sjogren C, Andersson K-E: Inhibition of ATP- induced contraction in the guinea-pig urinary bladder in vitro and in vivo. Acta Pharmacol Toxicol (Copenh) 44:221–227, 1979CrossRefGoogle Scholar
  151. 150.
    Stanton SL: A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence. J Urol 110:529–532, 1973PubMedGoogle Scholar
  152. 151.
    Stanton SL: Drugs acting on the bladder and urethra. Br Med J 1:1607–1608, 1978PubMedCrossRefGoogle Scholar
  153. 152.
    Taira N: Mode of actions of prostaglandin F2a on the urinary bladder and its arterial bed in the dog. Eur J Pharmacol 29:30–34, 1974PubMedCrossRefGoogle Scholar
  154. 153.
    Taira N: The autonomic pharmacology of the bladder. Annu Rev Pharmacol Toxicol 12:197–208, 1972Google Scholar
  155. 154.
    Tanagho EA, Meyers FH: The “internal sphincter”: Is it under sympathetic control? Invest Urol 7:79–89, 1969PubMedGoogle Scholar
  156. 155.
    Tanagho EA, Smith DR: Mechanism of urinary incontinence. I. Embryologic, anatomic and pathologic considerations. J Urol 100:640–646, 1968PubMedGoogle Scholar
  157. 156.
    Thompson IM, Lauvetz R: Oxybutynin in bladder spasm, neurogenic bladder and enuresis. Urology 8:452–454, 1976PubMedCrossRefGoogle Scholar
  158. 157.
    Todd JK, Mack AJ: A study of human bladder detrusor muscle. Br J Urol 41:448–454, 1969PubMedCrossRefGoogle Scholar
  159. 158.
    Tulloch AGS, Creed KE: A comparison between propantheline and imipramine on bladder and salivary gland function. Br J Urol 51:359–362, 1979PubMedCrossRefGoogle Scholar
  160. 159.
    Van Putten T, Malkin MD, Weiss MS: Phenothiazine-induced stress incontinence. J Urol 109:625–626, 1973PubMedGoogle Scholar
  161. 160.
    Weetman DF: The guinea-pig isolated, innervated bladder preparation: the effects of some autonomic drugs. Arch Int Pharmacodyn 196:383–392, 1972PubMedGoogle Scholar
  162. 161.
    Weetman DF, Turner N: The effects of ATP- receptor blocking agents on the response of the guinea pig isolated bladder preparation to hyoscine-resistant nerve stimulation. Arch Int Pharmacodyn 228:10–14, 1977PubMedGoogle Scholar
  163. 162.
    Weetman DF, Turner N: The effects of inhibitors of adenosine 5’-triphosphate biosynthesis on the responses of the guinea-pig isolated bladder and some other preparations to nerve stimulation. Arch Int Pharmacodyn 210:12–26, 1974PubMedGoogle Scholar
  164. 163.
    Wein AJ, Gregory JG, Sansone TC, Schoenberg HW: The effects of aminophylline on ureteral and bladder contractility. Invest Urol 9:290–293, 1972PubMedGoogle Scholar
  165. 164.
    Wein AJ, Hanno PM, Raezer DM, Benson GS: Effect of oxybutynin chloride on bladder spasm following transurethral surgery. Urology 12:184–186, 1978PubMedCrossRefGoogle Scholar
  166. 165.
    Welch LT, Bissada NK, Redman JF: Vesicotropic action of digitalis. Urology 5:361–364, 1975CrossRefGoogle Scholar
  167. 166.
    Woodburne RT: Structure and function of the urinary bladder. J Urol 84:79–85, 1960Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1983

Authors and Affiliations

  • Om P. Khanna

There are no affiliations available

Personalised recommendations